Scientist - Imaging Research and Development at Eli Lilly and Company

Philadelphia, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Degree in physical or biological sciences or imaging-related field
Bachelor’s degree with minimum of 10 years’ experience or master’s with a minimum of 8 years’ experience in scientific field

Responsibilities

Establish and execute imaging research projects supporting oncology, neuroscience or other drug discovery and biomarker projects
Design and conduct novel binding assays, including radioligand binding assays
Characterize and purify biological targets
Collaborate with internal project teams, implement translatable imaging biomarker assays and ensure seamless translation of projects
Publish results of research projects as appropriate
Participate in extramural scientific organizations and attend scientific symposia as well as workshops in order to continue educational/professional development
Other duties as assigned

Skills

Molecular Imaging

PET Imaging

Radioligand Binding Assays

Binding Assays

Biological Assay Development

Biomarker Assays

Data Analysis

Neuroscience Imaging

Oncology Imaging

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free